Editor’s Pick

James A. Dorn President Trump likes to say, “The word tariff is the most beautiful word in the dictionary”; tariffs “make our country rich” and “cost Americans nothing.” Yet, nothing could…

Jeffrey A. Singer In an interview by ABC News’ Jonathan Karl on March 9, White House National Economic Council Director Kevin Hassett said of President Trump’s tariffs on products imported…

The next step in the stock market will be very interesting. I’ve been discussing a potential Q1 correction since our MarketVision event the first week of January and it’s here.…

In this exclusive StockCharts video, Julius analyzes sector rotation in US markets, assessing recent damage and potential downside risks. He examines the Equal Weight RSP vs. Cap-Weighted SPX ratio and…

Things heated up this week on my daily market recap show, with support levels being busted without delay across the growth sectors.  Despite a decent up day on Friday for…

2025 is off to a rough start for stocks, but there are still some pockets of strength in the market. Year-to-date, SPY is down 1.73%, QQQ is down around 4%…

One thing to understand about sentiment measures is that they are contrarian. If investors are too bullish or too bearish, everyone has jumped on the bandwagon and now it is…

Stephen Slivinski and Yasmeen Kallash-Kyler Housing policy reform is tricky. Getting policy changes off the ground in the first place can be difficult and compliance after enactment may not be…

Alfredo Carrillo Obregon and Scott Lincicome On March 6, President Donald Trump exempted Canadian and Mexican imports that enter the US free of duty under the US-Mexico-Canada Agreement (USMCA) from the…

Jeffrey A. Singer As Josh Bloom and I wrote last November, the Food and Drug Administration (FDA) imposed onerous requirements on health care providers prescribing the effective drug clozapine to…